Quantitative analysis of kallikrein 15 gene expression in prostate tissue.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Urology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(05)64127-4PMID 12478190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The new human tissue kallikrein gene family: structure, function, and association to disease.

  2001cited by this paper
• Molecular Cloning of the Human Kallikrein 15 Gene (KLK15)

  2001cited by this paper
• Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.

  2001cited by this paper
• Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer

  2001cited by this paper
• Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue

  2001cited by this paper
• Activation of latent protease function of pro‐hk2, but not pro‐PSA, involves autoprocessing

  2001cited by this paper
• Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR.

  2001cited by this paper
• Phases of biomarker development for early detection of cancer.

  2001cited by this paper
• Preoperative serum prostate-specific antigen (PSA) below 10 microg/l predicts neither the presence of prostate cancer nor the rate of postoperative PSA failure.

  2001cited by this paper
• Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.

  2000influential reference
• Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.

  2000cited by this paper
• New nomenclature for the human tissue kallikrein gene family.

  2000cited by this paper
• Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.

  2000cited by this paper
• Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

  1999cited by this paper
• Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.

  1999cited by this paper
• Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases.

  1999cited by this paper
• Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2.

  1997cited by this paper
• Characterization of the Precursor of Prostate-specific Antigen

  1997cited by this paper
• Factors influencing the ratio of free to total prostate‐specific antigen in serum

  1997cited by this paper
• Expression of the gene coding for human prostate‐specific antigen and related hGK‐1 in benign and malignant tumors of the human prostate

  1990cited by this paper

• Drug Discovery Strategies for Kallikrein-Related Peptidases

  2025influential citation
• Prognostic impact of kallikrein‐related peptidase transcript levels in prostate cancer

  2023cites this paper
• Kallikrein gene family as biomarkers for recurrent prostate cancer

  2020cites this paper
• Identification of six novel alternative transcripts of the human kallikrein-related peptidase 15 (KLK15), using 3'RACE and high-throughput sequencing.

  2020cites this paper
• microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene

  2019cites this paper
• Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis.

  2018cites this paper
• Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer.

  2018cites this paper
• Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review

  2017cites this paper
• Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer

  2017cites this paper
• OV-MZ-6 ovarian cancer cells overexpressing kallikrein-related peptidases KLK4, 5, 6 and 7: effects on expression of cancer-related genes

  2016cites this paper
• Epigenetic Analysis of the Kallikrein Gene Family and Associated Pathways as a Novel Panel of Prostate Cancer Biomarkers

  2015cites this paper
• Neue Biomarker im Serum und im Urin zur Detektion des Prostatakarzinoms

  2015cites this paper
• Prostate-specific antigen and other serum and urine markers in prostate cancer.

  2014cites this paper
• Kallikreins are involved in an miRNA network that contributes to prostate cancer progression

  2014cites this paper
• Quantitative Analysis of Novel Prostate Cancer Markers in Tissue

  2014cites this paper
• Serum human kallikrein 7 represents a new marker for cervical cancer

  2014cites this paper
• Quantified KLK15 Gene Expression Levels Discriminate Prostate Cancer From Benign Tumors and Constitute a Novel Independent Predictor of Disease Progression

  2013cites this paper
• Kallikrein-related peptidase 15 (prostinogen)

  2013cites this paper
• Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens.

  2013cites this paper
• chapter 98 Prostate Cancer Tumor Markers

  2012cites this paper
• Prostate Cancer Tumor Markers

  2012cites this paper
• Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data

  2011cites this paper
• Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia

  2010cites this paper
• Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.

  2010cites this paper
• KLK15 is a prognostic marker for progression‐free survival in patients with radical prostatectomy

  2010cites this paper
• The kallikrein family of proteins as urinary biomarkers for the detection of prostate cancer.

  2009cites this paper
• Distribution of Human Tissue Kallikrein-Related Peptidases in Tissues and Biological Fluids: Localization, Hormonal Regulation and Physiological Functions in the Female Reproductive System

  2009cites this paper
• Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.

  2009cites this paper
• A comprehensive resequence analysis of the KLK15–KLK3–KLK2 locus on chromosome 19q13.33

  2009cites this paper
• Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker.

  2009cites this paper
• The Kallikrein-Related Peptidases hK2 and PSA with Emphasis on Genetic Variation, Secretion, and Sperm Motility

  2008cites this paper
• Détection des différentes formes du prostate-specific antigen et autres kallicréines dans le cancer de la prostate

  2008cites this paper
• Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy

  2008cites this paper
• New insights into the functional mechanisms and clinical applications of the kallikrein‐related peptidase family

  2007cites this paper
• Human tissue kallikreins: the cancer biomarker family.

  2007cites this paper
• Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.

  2007cites this paper
• Human tissue kallikreins : The cancer biomarker family q

  2007cites this paper
• Human tissue kallikreins, uPA and PAI-1 as prognostic markers in ovarian carcinoma

  2007cites this paper
• PSA and other tissue kallikreins for prostate cancer detection.

  2007cites this paper
• Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses.

  2007cites this paper
• Human tissue kallikreins as prognostic biomarkers and as potential targets for anticancer therapy

  2007cites this paper
• Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids.

  2007cites this paper
• Seminal Fluid Characterization for Male Fertility and Prostate Cancer: Kallikrein-Related Serine Proteases and Whole Proteome Approaches

  2007cites this paper
• The kallikrein world: an update on the human tissue kallikreins

  2006cites this paper
• Cellular distribution of human tissue kallikreins: immunohistochemical localization

  2006cites this paper
• The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition

  2006cites this paper
• Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.

  2005cites this paper
• Human tissue kallikrein gene family: applications in cancer.

  2005cites this paper
• Human tissue kallikreins: from gene structure to function and clinical applications.

  2005cites this paper
• Enzymatic profiling of human kallikrein 14 using phage-display substrate technology

  2005cites this paper
• Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?

  2005cites this paper
• A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo

  2005cites this paper
• Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.

  2005cites this paper
• Magmas expression in neoplastic human prostate

  2005cites this paper
• Development of sensitive immunoassays for free and total human glandular kallikrein 2.

  2004cites this paper
• Pharmacological and functional characterization of bradykinin B2 receptor in human prostate.

  2004cites this paper
• The emerging roles of human tissue kallikreins in cancer

  2004cites this paper
• Applicability of biomarkers in the early diagnosis of prostate cancer

  2004cites this paper
• The Tissue Kallikrein Family of Serine Proteases: Functional Roles in Human Disease and Potential as Clinical Biomarkers

  2004cites this paper
• Human tissue kallikreins: physiologic roles and applications in cancer.

  2004cites this paper
• Prostate cancer biomarkers: a current perspective

  2003cites this paper